Bevers, L., van Ewijk – Beneken Kolmer, E., Te Brake, H., & Burger, D. (2024). Development, validation and clinical implementation of a UPLC-MS/MS bioanalytical method for simultaneous quantification of cabotegravir and rilpivirine E-isomer in human plasma. Journal of Pharmaceutical & Biomedical Analysis, 238, N.PAG. https://doi.org/10.1016/j.jpba.2023.115832
Chicago Style (17th ed.) CitationBevers, L.A.H, E.W.J van Ewijk – Beneken Kolmer, H.M.L Te Brake, and D.M Burger. "Development, Validation and Clinical Implementation of a UPLC-MS/MS Bioanalytical Method for Simultaneous Quantification of Cabotegravir and Rilpivirine E-isomer in Human Plasma." Journal of Pharmaceutical & Biomedical Analysis 238 (2024): N.PAG. https://doi.org/10.1016/j.jpba.2023.115832.
MLA (9th ed.) CitationBevers, L.A.H, et al. "Development, Validation and Clinical Implementation of a UPLC-MS/MS Bioanalytical Method for Simultaneous Quantification of Cabotegravir and Rilpivirine E-isomer in Human Plasma." Journal of Pharmaceutical & Biomedical Analysis, vol. 238, 2024, p. N.PAG, https://doi.org/10.1016/j.jpba.2023.115832.